Press Releases
Cytheris appoints Damian Marron as chief executive officer
Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the appointment of Damian Marron as chief executive...
Press Releases
Sanofi Submits Application for Regulatory Approval for Lyxumia for...
Sanofi announced today that the marketing authorization application for Lyxumia, an investigational once-daily GLP-1 receptor agonist has been submitted for review to the Ministry...
Press Releases
FDA Correct to Delay Ruling on Gilead’s Controversial HIV...
AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider, welcomed the news today that the Food and Drug Administration (FDA) is delaying...
Press Releases
Problems Plague Medicare’s Method for Measuring Payment Errors American...
The American Association for Homecare reported in this week's Mobility Matters publication that the U.S. Department of Health and Human Services (HHS) has uncovered...
Press Releases
Acquisition of the Healthcare Business of Thomson Reuters by...
The previously announced $1.25 billion sale of the Thomson Reuters Healthcare business to an affiliate of Veritas Capital was completed today. The...
Press Releases
Allegro Diagnostics to Present at 2012 BIO International Convention
Allegro Diagnostics today announced its participation in the BIO Business Forum at the BIO International Convention, being held June 18-20 in Boston. ...
Press Releases
Japan Pharma Portfolio Finds Renewed Strength through Record Growth...
Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), announced the successful 2012 return of the Japanese Pharma Portfolio of events...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.